Return to site

Immunoprecipitation Market | Key Players are Thermo Fisher Scientific (US), Abcam (UK), Bio-Rad Laboratories (US), Merck KGaA (Germany), GenScript. (US)

The kits segment is projected to grow at the highest CAGR between 2018 and 2024.

· Medical Devices,Biotechnology

The growth of this market is majorly driven by the increasing research in the life sciences industry and the growing need to identify antigens associated with autoimmune diseases (through antigen-antibody interaction to understand disease mechanisms and develop relevant drugs targeting these diseases).

The kits segment is projected to grow at the highest CAGR between 2018 and 2024. Growth in this immunoprecipitation market can be attributed to factors such as the requirement for repeat purchase of kits, coupled with the increasing number of IP assays to isolate and purify antigens.

Immunoprecipitation Market

The individual IP segment is projected to grow at the highest rate in the market, by type. The increasing use of IP in studying protein-protein interactions, to detect the presence of an antigen, and to determine the relative quantity of an antigen are driving the use of individual IP in various research studies during the forecast period.

The Asia Pacific is estimated to grow at the highest CAGR during the forecast period. Increasing investments by governments and industries, growing biotechnology research in these regions, and rising awareness about personalized therapeutics are expected to drive the growth of these markets during the forecast period.

Early buyers will receive 10% customization on this report – https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=78538655

Key Players

Major immunoprecipitation vendors include Thermo Fisher Scientific (US), Abcam (UK), Bio-Rad Laboratories (US), Merck KGaA (Germany), GenScript. (US), and BioLegend (US), Cell Signaling Technology (US), Rockland Immunochemicals (US), Takara Bio (Japan), and Geno Technology (US).

All Posts
×

Almost done…

We just sent you an email. Please click the link in the email to confirm your subscription!

OKSubscriptions powered by Strikingly